The influence of women in shaping genomic technology policies is particularly evident in the realm of maternal and reproductive health. Policymaking now increasingly incorporates genomic technologies for prenatal screening and fertility treatments, emphasizing safe, accessible, and ethical applications tailored to women’s health needs.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.